Form CORRESP - Correspondence:
SEC Accession No. 0001867096-24-000152
Filing Date
2024-08-06
Accepted
2024-08-06 18:39:29
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9447
2 filename001.jpg GRAPHIC 184749
3 filename002.jpg GRAPHIC 243120
4 filename003.jpg GRAPHIC 170358
5 filename004.jpg GRAPHIC 67282
  Complete submission text file 0001867096-24-000152.txt   927126
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)